Beijing Tri Prime Gene Pharmaceutical Co (BJSE:920344) Float Percentage Of Total Shares Outstanding: 0.00% (As of Aug. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920344 Beijing Tri Prime Gene Pharmaceutical Co Ltd BJSE:920344
77 GF Score
Price ¥18.55
GF Value ¥25.94
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Beijing Tri Prime Gene Pharmaceutical Co Float Percentage Of Total Shares Outstanding?

Beijing Tri Prime Gene Pharmaceutical Co BJSE:920344 77 Float Percentage Of Total Shares Outstanding is 0.00% as of Aug. 02, 2026. GuruFocus rates BJSE:920344 with a GF Score™ of 77/100 and a GF Value™ of ¥25.94 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Beijing Tri Prime Gene Pharmaceutical Co's float shares is 0.00 Mil. Beijing Tri Prime Gene Pharmaceutical Co's total shares outstanding is 121.81 Mil. Beijing Tri Prime Gene Pharmaceutical Co's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Beijing Tri Prime Gene Pharmaceutical Co's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Beijing Tri Prime Gene Pharmaceutical Co's Institutional Ownership is 0.03%.

BJSE:920344
77GF Score
Beijing Tri Prime Gene Pharmaceutical Co Ltd BJSE:920344
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beijing Tri Prime Gene Pharmaceutical Co Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Beijing Tri Prime Gene Pharmaceutical Co's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/121.81
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 0.00% mean?
Beijing Tri Prime Gene Pharmaceutical Co (BJSE:920344) has a Float Percentage Of Total Shares Outstanding of 0.00% as of Aug. 02, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Beijing Tri Prime Gene Pharmaceutical Co and its competitors.
Is Beijing Tri Prime Gene Pharmaceutical Co's Float Percentage Of Total Shares Outstanding too high?
Beijing Tri Prime Gene Pharmaceutical Co's current Float Percentage Of Total Shares Outstanding is 0.00%. Overall, Beijing Tri Prime Gene Pharmaceutical Co has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beijing Tri Prime Gene Pharmaceutical Co's Float Percentage Of Total Shares Outstanding compare to VRTX and REGN?
Beijing Tri Prime Gene Pharmaceutical Co's Float Percentage Of Total Shares Outstanding of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Beijing Tri Prime Gene Pharmaceutical Co and its competitors. Beijing Tri Prime Gene Pharmaceutical Co's current Float Percentage Of Total Shares Outstanding is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Tri Prime Gene Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Beijing Tri Prime Gene Pharmaceutical Co (BJSE:920344) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥25.94, compared to a current price of ¥18.55 — trading 28.5% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 0.00%. Beijing Tri Prime Gene Pharmaceutical Co's overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Beijing Tri Prime Gene Pharmaceutical Co (BJSE:920344), the current Float Percentage Of Total Shares Outstanding is 0.00% as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Beijing Tri Prime Gene Pharmaceutical Co (BJSE:920344) Overvalued in 2026?

Based on GuruFocus' analysis, Beijing Tri Prime Gene Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥18.55 is trading 28.5% below its estimated GF Value™ of ¥25.94. GuruFocus considers Beijing Tri Prime Gene Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for BJSE:920344:

  • Float Percentage Of Total Shares Outstanding: 0.00%
  • GF Value™: ¥25.94 vs. price of ¥18.55 (28.5% below fair value)
  • GF Score™: 77/100 with 7 warning signs

No single metric tells the full story. See the BJSE:920344 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Beijing Tri Prime Gene Pharmaceutical Co Business Description

Address No. 20, Jinghong Street, Biomedicine Base, Daxing District, Beijing, CHN, 102600
Beijing Tri Prime Gene Pharmaceutical Co Ltd is mainly engaged in the research, development, production, and sales of medical biotechnology products, including genetic engineering drugs, genetic engineering vaccines, and diagnostic reagents, and is engaged in related technical trade and technical consulting services. Its product line comprises Yundex Spray, Yundex Eye Drops, Yundexol Powder Injection, and Yundexol Water Injection.
77GF Score

Get the complete analysis for BJSE:920344

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥18.55
Price
¥25.94
GF Value